Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement
Melbourne, Australia, October 28, 2022 – Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or… Read more